VGX-3100
HPV-201
Phase 2 mab completed
Quick answer
VGX-3100 for Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) is a Phase 2 program (mab) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INOVIO PHARMACEUTICALS, INC.
- Indication
- Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
- Phase
- Phase 2
- Modality
- mab
- Status
- completed